Harbor Investment Advisory’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,112
Closed -$111K 1385
2023
Q1
$111K Buy
3,112
+1,448
+87% +$52.5K 0.02% 472
2022
Q4
$61K Hold
1,664
0.01% 644
2022
Q3
$78K Hold
1,664
0.01% 535
2022
Q2
$119K Buy
1,664
+197
+13% +$14.4K 0.02% 457
2022
Q1
$119K Hold
1,467
0.02% 492
2021
Q4
$151K Hold
1,467
0.02% 436
2021
Q3
$128K Hold
1,467
0.02% 461
2021
Q2
$131K Hold
1,467
0.02% 452
2021
Q1
$111K Hold
1,467
0.02% 459
2020
Q4
$100K Buy
1,467
+463
+46% +$28.9K 0.02% 453
2020
Q3
$53K Buy
1,004
+480
+92% +$28.6K 0.01% 490
2020
Q2
$31K Hold
524
0.01% 535
2020
Q1
$21K Buy
+524
New +$30.6K 0.01% 573

Other funds holding SYNH

Harbor Investment Advisory's SYNH Position: Q2 2023 in Review

Harbor Investment Advisory sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 3,112 shares — an estimated $111K sold.

Harbor Investment Advisory first reported a position in SYNH in Q1 2020 and held it in 13 quarters. The position peaked at $151K in Q4 2021. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Harbor Investment Advisory reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Harbor Investment Advisory sold 3,112 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $111K.
  • Harbor Investment Advisory first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2020 and held it in 13 quarters.
  • Harbor Investment Advisory's Syneos Health, Inc. Class A Common Stock position peaked at $151K in Q4 2021.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Harbor Investment Advisory's 13F filing for Q2 2023, filed 14 Jul 2023.